Greinacher, A <br/><br/>
Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.  [electronic resource] 

 -  Circulation   
 - 73-80 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-7322 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.99.1.73  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--adverse effects<br/>Female<br/>Germany--epidemiology<br/>Hemorrhage--epidemiology<br/>Heparin--adverse effects<br/>Hirudin Therapy<br/>Hirudins--adverse effects<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins--adverse effects<br/>Retrospective Studies<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome